These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22363635)

  • 1. Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice.
    Lee J; Hong SW; Chae SW; Kim DH; Choi JH; Bae JC; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Lee WY
    PLoS One; 2012; 7(2):e31394. PubMed ID: 22363635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1.
    Xu F; Lin B; Zheng X; Chen Z; Cao H; Xu H; Liang H; Weng J
    Diabetologia; 2016 May; 59(5):1059-69. PubMed ID: 26924394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
    Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J
    Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis.
    Xu F; Li Z; Zheng X; Liu H; Liang H; Xu H; Chen Z; Zeng K; Weng J
    Diabetes; 2014 Nov; 63(11):3637-46. PubMed ID: 24947350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism.
    Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
    Cell Stress Chaperones; 2014 Sep; 19(5):649-56. PubMed ID: 24446069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
    Li H; Xu M; Lee J; He C; Xie Z
    Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1234-44. PubMed ID: 22967499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
    Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
    Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.
    Li X; Lian F; Liu C; Hu KQ; Wang XD
    Sci Rep; 2015 Nov; 5():16774. PubMed ID: 26608583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
    Wang X; He H; Liang LB; Zhang M; Li SY; Li SQ; An ZM; Huang HJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):28-32. PubMed ID: 28612554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity.
    Wei Q; Li L; Chen JA; Wang SH; Sun ZL
    Ann Clin Lab Sci; 2015; 45(2):158-65. PubMed ID: 25887869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
    Sharma S; Mells JE; Fu PP; Saxena NK; Anania FA
    PLoS One; 2011; 6(9):e25269. PubMed ID: 21957486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis.
    Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
    Metabolism; 2014 Aug; 63(8):1041-8. PubMed ID: 24933399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
    Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
    Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
    Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.